All The Claims – Page 1045 – Algorithmically generated claims as prior art

1461165953-dc592388-668d-4cb4-8bd9-358b8cbafb76

1. A method performed by a network device, comprising:
configuring the network device with an access control list including identification information for authorized client devices and proximity indicators associated with the client devices;
detecting a presence of a client device in proximity to the network device by receiving signals from nearby proximity indicators and decoding identification information from the received signals to determine that the client device is located within communication range of the network device;
determining that the client device is authorized to communicate with the network device by comparing the decoded identification information against the identification information included in the access control list;
turning-on, based on determining that the client device is authorized to communicate with the network device and detecting that the authorized client device is within communication range of the network device, a first signal that comprises:
information for enabling the authorized client device to decode and to access information in a second signal;

wherein the second signal enables communication with the network device;
transmitting the first signal to the authorized client device; and
ceasing transmission of the first signal after (i) initiating communication with the authorized client device, and (ii) determining establishment of a communication with the client device using the second signal, or a pre-set time limit.
2. The method of claim 1, further comprising:
transmitting the second signal continuously during a time when the network device is in service.
3. The method of claim 1, further comprises:
analyzing a property of the received signals to determine whether the client device is within communication range of the network device.
4. The method of claim 1, wherein (1) a detection of the presence of the client device uses a first communication modality, and (2) the communication with the network device uses a second, different communication modality.
5. The method of claim 4, wherein the first communication modality comprises radio frequency communication and the second communication modality comprises cellular communication.
6. A system comprising:
one or more processing devices; and
a non-transitory computer-readable medium configured to store instructions that are executable by the one or more processing devices to perform operations comprising:
configuring a network device with an access control list including identification information for authorized client devices and proximity indicators associated with the client devices;
detecting a presence of a client device in proximity to the network device by receiving signals from nearby proximity indicators and decoding identification information from the received signals to determine that the client device is located within communication range of the network device;
determining that the client device is authorized to communicate with the network device by comparing the decoded identification information against the identification information included in the access control list;
turning-on, based on determining that the client device is authorized to communicate with the network device and detecting that the authorized client device is within communication range of the network device, a first signal that comprises:
information for enabling the authorized client device to decode and to access information in a second signal;

wherein the second signal enables communication with the network device;
transmitting the first signal to the authorized client device; and
ceasing transmission of the first signal after (i) initiating communication with the authorized client device, and (ii) determining establishment of a communication with the client device using the second signal, or a pre-set time limit.
7. The system of claim 6, wherein the operations further comprise:
transmitting the second signal continuously during a time when the system is in service.
8. The system of claim 6, wherein the operations further comprise:
analyzing a property of the received signals to determine whether the client device is within communication range of the system.
9. The system of claim 6, wherein (1) a detection of the presence of the client device uses a first communication modality, and (2) the communication with the system uses a second, different communication modality.
10. The system of claim 9, wherein the first communication modality comprises radio frequency communication and the second communication modality comprises cellular communication.
11. A non-transitory computer-readable medium configured to store instructions that are executable by a network device to perform operations comprising:
configuring the network device with an access control list including identification information for authorized client devices and proximity indicators associated with the client devices;
detecting a presence of a client device in proximity to the network device by receiving signals from nearby proximity indicators and decoding identification information from the received signals to determine that the client device is located within communication range of the network device;
determining that the client device is authorized to communicate with the network device by comparing the decoded identification information against the identification information included in the access control list;
turning-on, based on determining that the client device is authorized to communicate with the network device and detecting that the authorized client device is within communication range of the network device, a first signal that comprises:
information for enabling the authorized client device to decode and to access information in a second signal;

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

1. A circuit protection device comprising:
a substrate;
a conducting layer disposed on said substrate, said conducting layer having at least a first and second terminals;
a resistive element disposed on said substrate;
a conducting pad disposed on said substrate, said conducting pad aligned with said resistive layer;
a dielectric layer disposed on said substrate between said resistive element and said conducting pad;
a spring disposed on said substrate, said spring having a first end electrically connected to said first terminal and a second end electrically connected to said second terminal; and
a low melting material disposed between said conducting pad and at least one of said first and second ends of said spring, wherein said spring has a first conducting position when said first and second ends are connected to respective first and second terminals, said spring having a second open position during an abnormal circuit condition when said resistive element heats said low melting material and at least one of said first and second ends of said spring are displaced away from at least one of said first and second terminals to create an open circuit.
2. The circuit protection device of claim 1 wherein said resistive element is a first resistive element, said device further comprising a second resistive element disposed on said substrate.
3. The circuit protection device of claim 1 further comprising a cover disposed over said spring and attached to said substrate.
4. The circuit protection device of claim 3 wherein said cover includes at least one extended portion configured to increase the surface area of said cover for attachment to said substrate.
5. The circuit protection device of claim 4 wherein said at least one extended portion is configured to receive an attaching material to bond said cover to said substrate.
6. The circuit protection device of claim 4 wherein said at least one extended portion has a textured lower surface configured to receive an attaching material to bond said cover to said substrate.
7. The circuit protection device of claim 4 wherein said at least one extended portion includes a through hole configured to receive an attaching material for locking said cover to said substrate.
8. The circuit protection device of claim 5 wherein said attaching material is an epoxy.
9. The circuit protection device of claim 1 wherein said first terminal and said second terminal are disposed within said device on a first plane.
10. The circuit protection device of claim 9 wherein said spring includes a first side and a second side and wherein when at least one of said first and second ends of said spring are displaced away from at least one of said first and second terminals to create an open circuit, the first side of said spring is displaced within the first plane toward said second side of said spring.
11. The circuit protection device of claim 9 wherein said spring includes a first side and a second side and wherein when at least one of said first and second ends of said spring are displaced away from at least one of said first and second terminals to create an open circuit, the first side of said spring is displaced vertically out of the first plane.
12. The circuit protection device of claim 9 wherein said spring includes a first side and a second side and wherein when at least one of said first and second ends of said spring are displaced away from at least one of said first and second terminals to create an open circuit, the second side of said spring is displaced vertically out of the first plane.
13. A circuit protection device comprising:
a substrate;
a conducting layer disposed on said substrate, said conducting layer having at least a first and second terminals;
a first and second resistive elements disposed on said substrate;
a spring disposed on said substrate, said spring having a first end electrically connected to said first terminal and a second end electrically connected to said second terminal; and
a first and second conducting pads disposed on said substrate between said first and second resistive elements and a low melting material, said first conducting pad aligned with said first resistive element and said second conducting pad aligned with said second resistive element, wherein said low melting material disposed between said first or second conductive pads and at least one of said first and second ends of said spring, wherein said spring has a first conducting position when said first and second ends are connected to respective first and second terminals, said spring having a second open position during an abnormal circuit condition when said resistive element heats said low melting material and at least one of said first and second ends of said spring are displaced away from at least one of said first and second terminals to create an open circuit.
14. The circuit protection device of claim 13 wherein said low melting material is a first portion of low melting material disposed on the first conducting pad to retain said first end of said spring in electrical contact with said first pad, said device further comprising a second portion of low melting material disposed on the second conducting pad to retain said second end of said spring in electrical contact with said second pad.
15. The circuit protection device of claim 14 further comprising a shunt connection disposed between said first and second conducting pads and said first and second ends of said spring, said shunt connection configured to carry the majority of current through said circuit protection device.
16. The circuit protection device of claim 14 wherein said second open position of said spring occurs when said first and second resistive elements heat said first and second portions of low melting material respectively, and at least one of said first and second ends of said spring are displaced away from at least one of said first and second terminals to create an open circuit.
17. A circuit protection device comprising:
a substrate;
a conducting layer disposed on said substrate, said conducting layer having at least a first and second terminals;
a resistive element disposed on said substrate;
a conducting pad disposed on said substrate, said conducting pad aligned with said resistive layer;
a first dielectric layer disposed on said substrate between said resistive element and said conducting pad;
a spring disposed on said substrate, said spring having a first end electrically connected to said first terminal and a second end electrically connected to said second terminal;
a second dielectric layer disposed on said substrate between said conducting pad and said spring; and
a low melting material disposed between the conducting pad and at least one of said first and second ends of said spring, wherein said spring has a first conducting position when said first and second ends are connected to respective first and second terminals, said spring having a second open position during an abnormal circuit condition when said resistive element heats said low melting material and at least one of said first and second ends of said spring are displaced away from at least one of said first and second terminals to create an open circuit.

1461165943-9c90bcac-4263-4048-8559-0c733da0e126

1. A method for the manufacture of amino polyalkylene phosphonic acid in presence of not more than 0.4% by weight, expressed in relation to the phosphorous acid component (100%), of hydrohalogenic acid, whereby all the available N\u2014H functions in 50% or more of the amine raw material are converted to the corresponding alkylene phosphonic acids, by reacting:
(a): phosphorous acid;
(b): an amine; and
(c): a formaldehyde;

in reactant ratios as follows:
(a):(b) of from 0.05:1 to 2:1;
(c):(b) of from 0.05:1 to 5:1; and
(c):(a) of from 5:1 to 0.25:1;

wherein (a) and (c) stand for the number of moles to be used and (b) represents the number of moles multiplied by the number of N\u2014H functions in the amine, in the presence of an acid catalyst having a pKa equal or inferior to 3.1, said acid catalyst (d) being homogeneous with respect to the reaction medium and being used in reactant ratios as follows:
(b):(d) of from 40:1 to 1:5;

wherein (d) stands for the number of moles of catalyst multiplied by the number of available protons per mole of catalyst, followed by recovering the amino polyalkylene phosphonic acid formed in a manner known per se.
2. The method in accordance with claim 1 wherein the reactant ratios are as follows:
(a):(b) of from 0.1:1 to 1.50:1;
(c):(b) of from 0.2:1 to 2:1; and
(c):(a) of from 3:1 to 0.5:1.
3. The method in accordance with claim 1 wherein the acid catalyst is used in a ratio (b):(d) in the range of from 20:1 to 1:3.
4. The method in accordance with claim 1 wherein the reaction is carried out at a temperature in the range of from 45\xb0 C. to 200\xb0 C.
5. The method in accordance with claim 1 wherein the acid catalyst is selected from the group of sulfuric acid, sulfurous acid, trifluoroacetic acid, trifluoromethane sulfonic acid, methane sulfonic acid, oxalic acid, malonic acid, p-toluene sulfonic acid and naphthalene sulfonic acid, and mixtures thereof.
6. The method in accordance with claim 1 wherein the reactant ratios are as follows:
(a):(b) of from 0.4:1 to 1.0:1.0;
(c):(b) of from 0.4:1 to 1.5:1; and
(c):(a) of from 2:1 to 1.0:1.
7. The method in accordance with claims 1 and 5 wherein the acid catalyst is used in a ratio (b):(d) in the range of from 10:1 to 1:2.
8. The method in accordance with any of the foregoing Claims wherein the reaction is carried out at a temperature in the range of from 70\xb0 C. to 150\xb0 C. combined with an approach selected from:
conducting the reaction under ambient pressure with or without distillation of water and non-reacted formaldehyde;
in a closed vessel under autogeneous pressure built up;
in a combined distillation and pressure arrangement whereby the reaction vessel containing the reactant mixture is kept under ambient pressure at the reaction temperature followed by circulating the reaction mixture through a reactor operated under autogeneous pressure built up thereby gradually adding the formaldehyde and other selected reactants in accordance with needs; and
a continuous process arrangement, possibly under autogeneous pressure built up, whereby the reactants are continuously injected into the reaction mixture and the phosphonic acid reaction product is withdrawn on a continuous basis.
9. The method in accordance with claim 1 wherein the amine is selected from the group of:
ammonia;
primary and secondary amines containing individual hydrocarbon groups having from 1 to 100 carbon atoms, said hydrocarbon moieties being represented by straight or branched linear alkyl moieties or cyclic alkyl moieties or aromatic or polyaromatic moieties or combinations thereof;
polyamines; and
primary and secondary amines or polyamines containing alkoxylated or thioalkoxylated radicals andor functional groups including trialkyl silyl, hydroxyl, carboxylic acid or sulfonic acid or esters of such acids or combinations thereof.
10. The method in accordance with claim 9 wherein the alkylamine is selected from methylamine, ethylamine, butylamine, octylamine, decylamine, dodecylamine, stearylamine, dimethylamine, diethylamine, dibutylamine, naphthylamine, benzylamine, aniline and cyclohexylamine.
11. The method in accordance with claims 1 and 7 wherein the acid catalyst has a pKa equal or inferior to 2.75.
12. The method in accordance with claim 1 wherein the phosphorous acid reactant is prepared, in a known manner, under substantial exclusion of halogen.
13. The method in accordance with claim 12 wherein the phosphorous acid is prepared, under substantial exclusion of halogen:
(i) by contacting elemental phosphorus with water at a temperature below 200\xb0 C. in the presence of a catalyst effective to promote oxidation of phosphorus by reaction with water; or
(ii) by contacting P(V) species with a reducing agent such as hydrogen in the presence of a reducing catalyst; or
(iii) by contacting a hydrolysis feed mixture comprising phosphite esters and phosphate esters with liquid water and steam to thereby hydrolyze the phosphite esters to phosphorous acid.
14. The method in accordance with claim 13 wherein the elemental phosphorus is tetraphosphorus.
15. The method in accordance with claims 1 and 9 wherein the polyamine is selected from the group of ethylene diamine, diethylene triamine, triethylene tetra-amine, di(propylene)ethylene tetra-amine, di(hexamethylene) triamine, hexamethylene diamine, polyethylene imine and polyallylamine.
16. The method in accordance with claim 1 wherein the phosphorous acid is prepared by reacting phosphorus trichloride with a reagent from the group of: a carboxylic acid; a sulfonic acid; and an alcohol followed by eliminating the chlorine containing products formed and the non-reacted raw materials by distillation or phase separation.
17. The method in accordance with claim 16 wherein chlorine containing products are eliminated to a level of 2000 parts-per-million (ppm) or smaller, expressed in relation to the level of the phosphorous acid component (100%)
18. The method in accordance with claim 1 wherein the phosphorous acid is prepared by hydrolyzing phosphorus trichloride followed by the substantial elimination of hydrochloric acid and other chloride intermediates originating from the hydrolysis.
19. The method in accordance with claim 18 wherein the hydrochloric acid and the chloride intermediates are eliminated to a level of. 2000 ppm of phosphorous acid component (100%).
20. The method in accordance with claim 1 wherein the acid catalyst has a pKa inferior to 1.9.
21. The method in accordance with claim 9 wherein the individual hydrocarbon groups in the primary and secondary amines have from 1 to 50 carbon atoms.

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

1. A tampon adapted to deliver a therapeutic agent to a tampon user, the tampon comprising:
a tampon body, wherein the tampon body is manufactured at a first manufacturing facility; and
a separate dosage form adapted to be coupled to the body, wherein the dosage form is not substantially liquefied when coupled to the tampon, wherein the dosage form includes a formulation including a therapeutic agent, wherein the dosage form is manufactured at a second manufacturing facility, wherein the dosage form and the tampon body are adapted to be sold separately to the tampon user, and wherein the tampon body and the dosage form are adapted such that the tampon user can attach the dosage form directly to the tampon body by partially melting the dosage form.
2. The tampon of claim 1, wherein partially melted dosage form partially absorbs into the tampon body.
3. The tampon of claim 1, wherein the dosage form is partially melted by heating the tampon body, and wherein the dosage form is attached to the tampon body by the tampon user contacting the dosage form with the tampon body.
4. A tampon adapted to deliver a therapeutic agent to a tampon user, the tampon comprising:
a tampon body, wherein the tampon body is manufactured at a first manufacturing facility; and
a separate dosage form adapted to be coupled to the tampon body, wherein the dosage form is not a film coating, wherein the dosage form includes a formulation including a therapeutic agent, wherein the dosage form is manufactured at a second manufacturing facility, wherein the dosage form and the tampon body are adapted to be sold separately to the tampon user, and wherein the tampon body and the dosage form are adapted such that the tampon user can attach the dosage form directly to the tampon body using a biologically-compatible adhesive.
5. The tampon of claim 4, wherein the dosage form includes the biologically-compatible adhesive, and wherein the biologically-compatible adhesive is protected by a covering.
6. A method for producing a medicated tampon for use by a tampon user, the method comprising:
manufacturing a tampon body at a first manufacturing facility;
manufacturing a dosage form at a second manufacturing facility, wherein the dosage form includes a formulation including a therapeutic agent;
providing the tampon body to the tampon user,
providing the dosage form to the tampon user; and
coupling the dosage form to the tampon body, wherein the coupling act is performed by the tampon user including partially melting the dosage form.
7. The method of claim 6, wherein the coupling act includes heating the tampon body, and contacting the dosage form with the tampon body to partially melt the dosage form.
8. A method for producing a medicated tampon for use by a tampon user, the method comprising:
manufacturing a tampon body at a first manufacturing facility;
manufacturing a dosage form at a second manufacturing facility, wherein the dosage form includes a formulation including a therapeutic agent;
providing the tampon body to the tampon user;
providing the dosage form to the tampon user; and
coupling the dosage form to the tampon body, wherein the coupling act is performed by the tampon user including affixing the dosage form to the tampon body using a biologically-compatible adhesive.
9. The method of claim 8, wherein the coupling act includes removing a protective covering from the biologically-compatible adhesive.
10. A method of making a medicated tampon for use by a tampon user, the method comprising:
providing a tampon;
procuring a dosage form comprising a dose of a therapeutic agent; and
providing the dosage form and the tampon to a tampon user, wherein the dosage form and the tampon are adapted such that the tampon user can attach the dosage form directly to the tampon body.
11. The method of claim 10, wherein the dose of the therapeutic agent remains substantially unchanged.
12. The method of claim 10, wherein the dosage form is attached to the tampon by partially melting the dosage form.
13. The method of claim 10, wherein the dosage form is attached to the tampon using a biologically-compatible adhesive.
14. The method of claim 10, wherein the tampon includes a tampon body, and wherein the dosage form is attached to the tampon by heating the tampon body and contacting the dosage form with the tampon body to partially melt the dosage form.
15. The method of claim 14, wherein a portion of the dosage form remains substantially intact.
16. The method of claim 14, wherein the dosage form is not substantially liquefied when coupled to the tampon.
17. The method of claim 14, wherein the tampon includes a distal end, and wherein the dosage form is positioned at the distal end of the tampon.
18. A method of making a medicated tampon for use by a tampon user, the method comprising the steps of:
providing a tampon;
procuring a dosage form comprising a dose of a therapeutic agent; and
providing the dosage form and the tampon to a tampon user, wherein the dosage form and the tampon are adapted such that the tampon user can place the dosage form adjacent to the tampon within a tube.
19. The method of claim 18, wherein the dosage form remains substantially intact.
20. The method of claim 18, wherein the tampon includes a distal end, and wherein the dosage form is placed at the distal end of the tampon.
21. A tampon adapted to deliver a therapeutic agent to a tampon user, the tampon comprising:
a tampon body; and
a dosage form adapted to be coupled to the body;
wherein the dosage form comprises a shape selected from the group consisting of a tablet, capsule, suppository, disk, and lozenge;
wherein the dosage form includes a formulation including a therapeutic agent; and
wherein the tampon body and the dosage form are adapted such that the tampon user can attach the dosage form directly to the tampon body by partially melting the dosage form.